{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:40:02Z","timestamp":1749138002279,"version":"3.41.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00059-025-05305-1","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:45:27Z","timestamp":1743389127000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update kardiovaskul\u00e4re Pr\u00e4vention 2025","Update on cardiovascular prevention 2025"],"prefix":"10.1007","volume":"50","author":[{"given":"Harm","family":"Wienbergen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Hanses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatim","family":"Kerniss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Hambrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"5305_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10654-023-00995-5","volume":"38","author":"D Jasilionis","year":"2023","unstructured":"Jasilionis\u00a0D, van Raalte\u00a0AA, Kluesener\u00a0S, Grigoriev\u00a0P (2023) The underwhelming German life expectancy. Eur J Epidemiol 38:839\u2013850","journal-title":"Eur J Epidemiol"},{"key":"5305_CR2","unstructured":"Joossens L, Olefir L, Feliu A, Fernandez E (2022) The Tobacco Control Scale 2021 in Europe. 2022. http:\/\/www.tobaccocontrolscale.org\/TCS2021"},{"key":"5305_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02478-3","author":"H Kerniss","year":"2024","unstructured":"Kerniss\u00a0H, Mata\u00a0MLA, Clemens\u00a0K et\u00a0al (2024) Long-term risk factor management and adverse events in patients with early-onset myocardial infarction\u2014a \u201creal-world\u201d study. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-024-02478-3","journal-title":"Clin Res Cardiol"},{"key":"5305_CR4","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren\u00a0FLJ, Mach\u00a0F, Smulders\u00a0YM et\u00a0al (2021) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart\u00a0J 42:3227\u20133337","journal-title":"Eur Heart J"},{"key":"5305_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/eurheartj\/ehad881","volume":"45","author":"K Schuett","year":"2024","unstructured":"Schuett\u00a0K, Federici\u00a0M, Verket\u00a0M, Marx\u00a0N, Mueller-Wieland\u00a0D (2024) The \u201810 commandments\u2019 for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart\u00a0J 45:1298\u20131300","journal-title":"Eur Heart J"},{"key":"5305_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5960\/dzsm.2017.307","volume":"68","author":"H Gohlke","year":"2017","unstructured":"Gohlke\u00a0H (2017) Smoking cessation\u2014an update. Dtsch Z Sportmed 68:281\u2013286","journal-title":"Dtsch Z Sportmed"},{"key":"5305_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamainternmed.2015.0533","volume":"175","author":"H Arem","year":"2015","unstructured":"Arem\u00a0H, Moore\u00a0SC, Patel\u00a0A et\u00a0al (2015) Leisure time physical activity and mortality: a\u00a0detailed pooled analysis of the dose-response relationship. JAMA Intern Med 175:959\u2013967","journal-title":"JAMA Intern Med"},{"key":"5305_CR8","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.jacc.2018.08.2163","volume":"72","author":"DJ Maron","year":"2018","unstructured":"Maron\u00a0DJ, Mancini\u00a0GBJ, Hartigan\u00a0PM et\u00a0al (2018) Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. J\u00a0Am Coll Cardiol 72:2297\u20132305","journal-title":"J Am Coll Cardiol"},{"key":"5305_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","volume":"121","author":"CK Chow","year":"2010","unstructured":"Chow\u00a0CK, Jolly\u00a0S, Rao-Melacini\u00a0P, Fox\u00a0KA, Anand\u00a0SS, Yusuf\u00a0S (2010) Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 121:750\u2013758","journal-title":"Circulation"},{"key":"5305_CR10","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1001\/jama.283.23.3095","volume":"283","author":"R Hambrecht","year":"2000","unstructured":"Hambrecht\u00a0R, Gielen\u00a0S, Linke\u00a0A et\u00a0al (2000) Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A\u00a0randomized trial. JAMA 283:3095\u20133101","journal-title":"JAMA"},{"key":"5305_CR11","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.jacc.2011.06.054","volume":"58","author":"F Edelmann","year":"2011","unstructured":"Edelmann\u00a0F, Gelbrich\u00a0G, Dungen\u00a0HD et\u00a0al (2011) Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J\u00a0Am Coll Cardiol 58:1780\u20131791","journal-title":"J Am Coll Cardiol"},{"key":"5305_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1161\/CIRCULATIONAHA.110.939959","volume":"122","author":"S Gielen","year":"2010","unstructured":"Gielen\u00a0S, Schuler\u00a0G, Adams\u00a0V (2010) Cardiovascular effects of exercise training: molecular mechanisms. Circulation 122:1221\u20131238","journal-title":"Circulation"},{"key":"5305_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJM200002173420702","volume":"342","author":"R Hambrecht","year":"2000","unstructured":"Hambrecht\u00a0R, Wolf\u00a0A, Gielen\u00a0S et\u00a0al (2000) Effect of exercise on coronary endothelial function in patients with coronary artery disease. N\u00a0Engl J Med 342:454\u2013460","journal-title":"N Engl J Med"},{"key":"5305_CR14","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/01.CIR.0000121360.31954.1F","volume":"109","author":"R Hambrecht","year":"2004","unstructured":"Hambrecht\u00a0R, Walther\u00a0C, Moebius-Winkler\u00a0S et\u00a0al (2004) Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a\u00a0randomized trial. Circulation 109:1371\u20131378","journal-title":"Circulation"},{"key":"5305_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/eurheartj\/ehac747","volume":"44","author":"GO Dibben","year":"2023","unstructured":"Dibben\u00a0GO, Faulkner\u00a0J, Oldridge\u00a0N, Rees\u00a0K, Thompson\u00a0DR, Zwisler\u00a0AD, Taylor\u00a0RS (2023) Exercise-based cardiac rehabilitation for coronary heart disease: a\u00a0meta-analysis. Eur Heart\u00a0J 44:452\u2013469","journal-title":"Eur Heart J"},{"key":"5305_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jacc.2017.08.017","volume":"70","author":"RAH Stewart","year":"2017","unstructured":"Stewart\u00a0RAH, Held\u00a0C, Hadziosmanovic\u00a0N et\u00a0al (2017) Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. J\u00a0Am Coll Cardiol 70:1689\u20131700","journal-title":"J Am Coll Cardiol"},{"key":"5305_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jama.2023.10875","volume":"330","author":"S Khurshid","year":"2023","unstructured":"Khurshid\u00a0S, A\u2011Alusi MA, Churchill\u00a0TW et\u00a0al (2023) Accelerometer-Derived \u201cWeekend Warrior\u201d Physical Activity and Incident Cardiovascular Disease. JAMA 330:247\u2013252","journal-title":"JAMA"},{"key":"5305_CR18","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","volume":"378","author":"R Estruch","year":"2018","unstructured":"Estruch\u00a0R, Ros\u00a0E, Salas-Salvado\u00a0J et\u00a0al (2018) Primary Prevention of Cardiovascular Disease with a\u00a0Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N\u00a0Engl J Med 378:e34","journal-title":"N Engl J Med"},{"key":"5305_CR19","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","volume":"399","author":"J Delgado-Lista","year":"2022","unstructured":"Delgado-Lista\u00a0J, Alcala-Diaz\u00a0JF, Torres-Pena\u00a0JD et\u00a0al (2022) Long-term secondary prevention of cardiovascular disease with a\u00a0Mediterranean diet and a\u00a0low-fat diet (CORDIOPREV): a\u00a0randomised controlled trial. Lancet 399:1876\u20131885","journal-title":"Lancet"},{"key":"5305_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration","year":"2024","unstructured":"NCD Risk Factor Collaboration (2024) Worldwide trends in underweight and obesity from 1990 to 2022: a\u00a0pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403:1027\u20131050","journal-title":"Lancet"},{"key":"5305_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2022.10.013","volume":"81","author":"LJ Laffin","year":"2023","unstructured":"Laffin\u00a0LJ, Bruemmer\u00a0D, Garcia\u00a0M et\u00a0al (2023) Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers. J\u00a0Am Coll Cardiol 81:1\u201312","journal-title":"J Am Coll Cardiol"},{"key":"5305_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00059-023-05226-x","volume":"49","author":"B Maisch","year":"2024","unstructured":"Maisch\u00a0B (2024) Canada\u2019s guidance on alcohol and health : A\u00a0paradigm shift. Herz 49:43\u201349","journal-title":"Herz"},{"key":"5305_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00059-024-05280-z","volume":"49","author":"B Maisch","year":"2024","unstructured":"Maisch\u00a0B (2024) Alcohol consumption-none is better than a\u00a0little. Herz 49:409\u2013419","journal-title":"Herz"},{"key":"5305_CR24","doi-asserted-by":"publisher","first-page":"k4247","DOI":"10.1136\/bmj.k4247","volume":"363","author":"ERC Millett","year":"2018","unstructured":"Millett\u00a0ERC, Peters\u00a0SAE, Woodward\u00a0M (2018) Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ 363:k4247","journal-title":"BMJ"},{"key":"5305_CR25","doi-asserted-by":"publisher","first-page":"j5855","DOI":"10.1136\/bmj.j5855","volume":"360","author":"A Hackshaw","year":"2018","unstructured":"Hackshaw\u00a0A, Morris\u00a0JK, Boniface\u00a0S, Tang\u00a0JL, Milenkovic\u00a0D (2018) Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55\u00a0study reports. BMJ 360:j5855","journal-title":"BMJ"},{"key":"5305_CR26","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/eurjpc\/zwac132","volume":"29","author":"H Wienbergen","year":"2022","unstructured":"Wienbergen\u00a0H, Boakye\u00a0D, Guenther\u00a0K et\u00a0al (2022) Lifestyle and metabolic risk factors in patients with early-onset myocardial infarction: A\u00a0case-control study. Eur J Prev Cardiol 29:2076\u20132087","journal-title":"Eur J Prev Cardiol"},{"key":"5305_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/2047487313483610","volume":"21","author":"J Schmucker","year":"2014","unstructured":"Schmucker\u00a0J, Wienbergen\u00a0H, Seide\u00a0S et\u00a0al (2014) Smoking ban in public areas is associated with a\u00a0reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the BREMEN STEMI REGISTRY. Eur J Prev Cardiol 21:1180\u20131186","journal-title":"Eur J Prev Cardiol"},{"key":"5305_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1055\/a-2282-9908","volume":"78","author":"A Rupp","year":"2024","unstructured":"Rupp\u00a0A, Sommer\u00a0N, Andreas\u00a0S et\u00a0al (2024) Medizinische Fachgesellschaften fordern ein Verbot von Aromen in E\u2011Zigaretten \u2013 Positionspapier der Deutschen Gesellschaft f\u00fcr Pneumologie (DGP) in Kooperation mit anderen Fachgesellschaften. Pneumologie 78:320\u2013324","journal-title":"Pneumologie"},{"key":"5305_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00059-024-05278-7","volume":"49","author":"T Muenzel","year":"2024","unstructured":"Muenzel\u00a0T, Kuntic\u00a0M, Stamm\u00a0P, Daiber\u00a0A (2024) E\u2011cigarettes and vaping, new spotlight on smoking as an old cardiovascular risk factor? Herz 49:441\u2013447","journal-title":"Herz"},{"key":"5305_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00059-024-05282-x","volume":"49","author":"J Sharkova","year":"2024","unstructured":"Sharkova\u00a0J, Nickolaus\u00a0T, Schaefer\u00a0JR (2024) Effects of cannabis use on the heart. Herz 49:420\u2013427","journal-title":"Herz"},{"key":"5305_CR31","doi-asserted-by":"publisher","first-page":"zsae08","DOI":"10.1093\/sleep\/zsae084","volume":"47","author":"L He","year":"2024","unstructured":"He\u00a0L, Ma\u00a0T, Wang\u00a0X, Cheng\u00a0X, Bai\u00a0Y (2024) Association between longitudinal change of sleep patterns and the risk of cardiovascular diseases. Sleep 47:zsae8","journal-title":"Sleep"},{"key":"5305_CR32","doi-asserted-by":"publisher","first-page":"e029463","DOI":"10.1161\/JAHA.123.029463","volume":"12","author":"J Zhang","year":"2023","unstructured":"Zhang\u00a0J, Chen\u00a0L, Zhang\u00a0S et\u00a0al (2023) Associations of Sleep Patterns With Dynamic Trajectory of Cardiovascular Multimorbidity and Mortality: A\u00a0Multistate Analysis of a\u00a0Large Cohort. J\u00a0Am Heart Assoc 12:e29463","journal-title":"J Am Heart Assoc"},{"key":"5305_CR33","first-page":"e26296","volume":"14","author":"ZI Warriach","year":"2022","unstructured":"Warriach\u00a0ZI, Patel\u00a0S, Khan\u00a0F, Ferrer\u00a0GF (2022) Association of Depression With Cardiovascular Diseases. Cureus 14:e26296","journal-title":"Cureus"},{"key":"5305_CR34","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference\u00a0BA, Ginsberg\u00a0HN, Graham\u00a0I et\u00a0al (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A\u00a0consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart\u00a0J 38:2459\u20132472","journal-title":"Eur Heart J"},{"key":"5305_CR35","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine\u00a0MS, Giugliano\u00a0RP, Keech\u00a0AC et\u00a0al (2017) Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N\u00a0Engl J Med 376:1713\u20131722","journal-title":"N Engl J Med"},{"key":"5305_CR36","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz\u00a0GG, Steg\u00a0PG, Szarek\u00a0M et\u00a0al (2018) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N\u00a0Engl J Med 379:2097\u20132107","journal-title":"N Engl J Med"},{"key":"5305_CR37","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/eurheartj\/ehx450","volume":"39","author":"BA Ference","year":"2018","unstructured":"Ference\u00a0BA, Cannon\u00a0CP, Landmesser\u00a0U, Luescher\u00a0TF, Catapano\u00a0AL, Ray\u00a0KK (2018) Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type\u00a09 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart\u00a0J 39:2540\u20132545","journal-title":"Eur Heart J"},{"key":"5305_CR38","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"SE Nissen","year":"2023","unstructured":"Nissen\u00a0SE, Lincoff\u00a0AM, Brennan\u00a0D et\u00a0al (2023) Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N\u00a0Engl J Med 388:1353\u20131364","journal-title":"N Engl J Med"},{"key":"5305_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ehjcvp\/pvad103","volume":"10","author":"T Horie","year":"2024","unstructured":"Horie\u00a0T, Ono\u00a0K (2024) VERVE-101: a\u00a0promising CRISPR-based gene editing therapy that reduces LDL\u2011C and PCSK9 levels in HeFH patients. Eur Heart J Cardiovasc Pharmacother 10:89\u201390","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"5305_CR40","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman\u00a0B, Wanner\u00a0C, Lachin\u00a0JM et\u00a0al (2015) Empagliflozin, Cardiovascular Outcomes, and Mortality in Type\u00a02 Diabetes. N\u00a0Engl J Med 373:2117\u20132128","journal-title":"N Engl J Med"},{"key":"5305_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott\u00a0SD, Raz\u00a0I, Bonaca\u00a0MP et\u00a0al (2019) Dapagliflozin and Cardiovascular Outcomes in Type\u00a02 Diabetes. N\u00a0Engl J Med 380:347\u2013357","journal-title":"N Engl J Med"},{"key":"5305_CR42","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray\u00a0JJV, Solomon\u00a0SD, Inzucchi\u00a0SE et\u00a0al (2019) Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N\u00a0Engl J Med 381:1995\u20132008","journal-title":"N Engl J Med"},{"key":"5305_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer\u00a0M, Anker\u00a0SD, Butler\u00a0J et\u00a0al (2020) Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N\u00a0Engl J Med 383:1413\u20131424","journal-title":"N Engl J Med"},{"key":"5305_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar\u00a0N, Lee\u00a0MMY, Kristensen\u00a0SL et\u00a0al (2021) Cardiovascular, mortality, and kidney outcomes with GLP\u20111 receptor agonists in patients with type\u00a02 diabetes: a\u00a0systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol 9:653\u2013662","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5305_CR45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding\u00a0JPH, Batterham\u00a0RL, Calanna\u00a0S et\u00a0al (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity. N\u00a0Engl J Med 384:989","journal-title":"N Engl J Med"},{"key":"5305_CR46","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff\u00a0AM, Brown-Frandsen\u00a0K, Colhoun\u00a0HM et\u00a0al (2023) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N\u00a0Engl J Med 389:2221\u20132232","journal-title":"N Engl J Med"},{"key":"5305_CR47","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biomedicines12061320","volume":"12","author":"F Sztanek","year":"2024","unstructured":"Sztanek\u00a0F, Toth\u00a0LI, Peto\u00a0A, Hernyak\u00a0M, Dioszegi\u00a0A, Harangi\u00a0M (2024) New Developments in Pharmacological Treatment of Obesity and Type\u00a02 Diabetes-Beyond and within GLP\u20111 Receptor Agonists. Biomedicines 12:1320","journal-title":"Biomedicines"},{"key":"5305_CR48","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy\u00a0JW, McCarthy\u00a0CP, Bruno\u00a0RM et\u00a0al (2024) 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart\u00a0J 45:3912\u20134018","journal-title":"Eur Heart J"},{"key":"5305_CR49","first-page":"B746","volume":"13","author":"R Beerheide","year":"2024","unstructured":"Beerheide\u00a0R, Martin\u00a0M (2024) Gesundes-Herz-Gesetz. Diskussion um Pr\u00e4vention mit Statinen. Dtsch \u00c4rztebl 13:B746\u2013B747","journal-title":"Dtsch \u00c4rztebl"},{"key":"5305_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/2047487318781109","volume":"26","author":"H Wienbergen","year":"2019","unstructured":"Wienbergen\u00a0H, Fach\u00a0A, Meyer\u00a0S et\u00a0al (2019) Effects of an intensive long-term prevention programme after myocardial infarction\u2014a\u00a0randomized trial. Eur J Prev Cardiol 26:522\u2013530","journal-title":"Eur J Prev Cardiol"},{"key":"5305_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amjcard.2021.05.034","volume":"154","author":"R Osteresch","year":"2021","unstructured":"Osteresch\u00a0R, Fach\u00a0A, Frielitz\u00a0FS et\u00a0al (2021) Long-Term Effects of an Intensive Prevention Program After Acute Myocardial Infarction. Am J Cardiol 154:7\u201313","journal-title":"Am J Cardiol"},{"key":"5305_CR52","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12181-019-00347-2","volume":"13","author":"H Wienbergen","year":"2019","unstructured":"Wienbergen\u00a0H, Gielen\u00a0S, Gysan\u00a0D, Albus\u00a0C, Landmesser\u00a0U, Hambrecht\u00a0R (2019) Sachkunde \u201eSpezielle kardiovaskul\u00e4re Pr\u00e4vention\u201c der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung e.\u202fV. Kardiologe 13:346\u2013351","journal-title":"Kardiologe"},{"key":"5305_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12181-021-00519-z","volume":"16","author":"H Wienbergen","year":"2022","unstructured":"Wienbergen\u00a0H, Jacobs\u00a0M, Schwaab\u00a0B, Albus\u00a0C, Landmesser\u00a0U, Hambrecht\u00a0R (2022) Curriculum \u201eKardiovaskul\u00e4re Pr\u00e4ventions-Assistenz der DGK\u201c. Kardiologe 16:34\u201337","journal-title":"Kardiologe"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05305-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05305-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05305-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:02:59Z","timestamp":1749135779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05305-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5305"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05305-1","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"18 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"H.\u00a0Wienbergen, U.\u00a0Hanses, H.\u00a0Kerniss und R.\u00a0Hambrecht geben an, dass kein Interessenkonflikt besteht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}